跳至主要内容
临床试验/NCT00140933
NCT00140933终止3 期

A Randomized, Double-Blind, 7-Day Study of the Efficacy and Safety of Rofecoxib Versus Placebo and Diclofenac in Patients With Acute Painful Rotator Cuff Syndrome

Merck Sharp & Dohme LLC2 个研究点 分布在 1 个国家目标入组 274 人开始时间: 2003年4月最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
终止
入组人数
274
试验地点
2
主要终点
Pain during daily activities assessed by a Numerical Rating Score (NRS)

研究概览

简要总结

Comparing the short-term efficacy of rofecoxib versus placebo. Patients receive rofecoxib or placebo or diclofenac and fill out a patient diary on daytime pain severity during daily activities, night pain severity, and acetaminophen/paracetamol intake.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 59 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Males or females between the ages of 18 and 59 with acute painful rotator cuff syndrome.

排除标准

  • 未提供

结局指标

主要结局

Pain during daily activities assessed by a Numerical Rating Score (NRS)

次要结局

  • Functional impairment evaluated using Neer's functional index.
  • Global assessment of disease activity by the patient with a NRS.
  • Intensity of night pain evaluated by NRS.
  • Rescue treatment take during the study duration.

研究者

申办方类型
Industry

研究点 (2)

Loading locations...

相似试验